HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.

More in this Section

Poll puts main parties neck-and-neck in country's support

March against homelessness takes place in Dublin

Gardaí search for man missing for two days

GSOC to investigate woman's death in road collision amid Garda pursuit


You might also like

Today's Stories

‘First Dates’ star faces harassment charge

‘Stellar’ leader Josephine Feehily not afraid of courting controversy

Questions about Nóirín O’Sullivan as Garda boss

Man ‘a victim of webcam honey trap scam’

Lifestyle

Labels to watch out for: Five Irish designers you need to know about

Orla Brady on playing designer and architect Eileen Gray in new movie

Highlights from the Ballymaloe Literary Festival of Food and Wine

What to watch on TV this week

More From The Irish Examiner